CYCLE PHARMACEUTICALS LTD
Summary
CYCLE PHARMACEUTICALS LTD was set up on Thursday, February 2, 2012. Their current partial address is THE BROERS BUILDING and the company status is Active.
Credit Score
Latest Accounts Filed:
31/12/2023
Next Set of Accounts Due:
30/09/2025
Company Vitals
Company Name:
CYCLE PHARMACEUTICALS LTD
Time in Business:
12 years
Company Number:
07933058
Current Status:
Active
Company Category:
Private Limited Company
Country of Origin:
United Kingdom
Principal Activity:
[21100] - Manufacture of basic pharmaceutical products
Registered Address:
THE BROERS BUILDING
J J THOMSON AVENUE
CAMBRIDGE
ENGLAND
CB3 0FA
Filing History
Submission | Date | Type |
---|---|---|
Termination director company with name termination date | 2024-10-09 | TM01 |
Accounts with accounts type full | 2024-08-27 | AA |
Confirmation statement with no updates | 2024-02-13 | CS01 |
Accounts with accounts type full | 2023-06-08 | AA |
Confirmation statement with no updates | 2023-02-13 | CS01 |
Termination director company with name termination date | 2022-09-20 | TM01 |
Accounts with accounts type full | 2022-08-25 | AA |
Confirmation statement with no updates | 2022-02-15 | CS01 |
Termination director company with name termination date | 2021-12-22 | TM01 |
Appoint person director company with name date | 2021-12-22 | AP01 |
Termination director company with name termination date | 2021-09-29 | TM01 |
Termination director company with name termination date | 2021-09-29 | TM01 |
Termination director company with name termination date | 2021-09-29 | TM01 |
Termination director company with name termination date | 2021-09-29 | TM01 |
Appoint person director company with name date | 2021-09-29 | AP01 |
Appoint person director company with name date | 2021-09-29 | AP01 |
Appoint person director company with name date | 2021-09-29 | AP01 |
Accounts with accounts type full | 2021-09-08 | AA |
Change to a person with significant control | 2021-07-22 | PSC05 |
Change registered office address company with date old address new address | 2021-05-12 | AD01 |